I'm Anne Beaumont. I've worked in clinical aesthetics in Paris for 38 years, with a focus on skin conditions brought on by hormonal disruption.
Three months back, a woman approached my pop-up consultation booth at a wellness expo in Phoenix. Her name was Margaret Anders. She was 56. She'd dropped 78 pounds on Wegovy between January and September of the previous year.
She pulled up two photos on her phone. The first was from 14 months prior, taken just weeks before she'd started the medication. Her arms in that picture looked ordinary. Healthy. Appropriate for her age.
Then she showed me her arms as they looked now.
The skin had shifted from smooth to crepey. Sagging. Thin like paper. Hollow. The kind of texture I'd typically only see on a woman 15 years her senior.
"My dermatologist told me it's just loose skin," Margaret said. "She said to give it time. That was nine months back."
That's the moment it clicked for me. This wasn't simply "loose skin." This was something distinct. And by then I'd already seen it dozens of times over the prior 18 months — nearly always in women who'd lost weight using Mounjaro, Ozempic, Wegovy, or Zepbound.
I spent that entire weekend going through my client files from the past two years. What I uncovered left me furious at my own field.
Eleven women. The exact same pattern. Every single one on a GLP-1 medication. Every single one given the identical line by their American dermatologist: "give it time, it'll tighten up on its own."
It does not tighten on its own. And we've overlooked the obvious answer for two whole years.